Global, regional, and national burden of varicella-zoster infections in adults aged 70 years and older from 1997 to 2021: Findings from the Global Burden of Disease Study
Chenchen Yang , Zhenpeng Guo , Xiaowei Deng , Yanling Wei , Qun Zhang , Jianming Wang
{"title":"Global, regional, and national burden of varicella-zoster infections in adults aged 70 years and older from 1997 to 2021: Findings from the Global Burden of Disease Study","authors":"Chenchen Yang , Zhenpeng Guo , Xiaowei Deng , Yanling Wei , Qun Zhang , Jianming Wang","doi":"10.1016/j.jiph.2025.102868","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Varicella-zoster virus (VZV) infection gives rise to varicella (chickenpox) and herpes zoster (HZ, shingles). Primary VZV infection results in varicella, while HZ occurs as a consequence of latent VZV reactivation. Older adults are at a significantly elevated risk of HZ because of age-related immune senescence. This study was designed to evaluate the global burden and trends of VZV-related diseases (VHZ: varicella and HZ) among adults aged ≥70 years from 1997 to 2021 and to explore the influencing factors. In this specific age group, VHZ predominantly refers to HZ.</div></div><div><h3>Methods</h3><div>Data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 were employed to estimate the incidence, disability-adjusted life years (DALYs), and rates of VHZ in older adults. Estimated annual percentage changes were utilized to quantify trends, and demographic decomposition analysis was conducted to determine the impacts of population aging, growth, and epidemiological changes.</div></div><div><h3>Results</h3><div>In 2021, a total of 4,539,519 new VHZ cases were reported globally among older adults, with an incidence rate of 918.2 per 100,000. The global DALYs attributable to VHZ amounted to 113,013, corresponding to a DALY rate of 22.9 per 100,000. From 1997 to 2021, although the incidence rate increased slightly, the DALY rate declined significantly. Population growth was the main driver of the increase in the number of cases, whereas enhanced disease management contributed to the reduction in DALYs.</div></div><div><h3>Conclusions</h3><div>From 1997 to 2021, the incidence of VHZ in adults aged ≥70 years increased marginally due to population growth, while the disease burden (measured by DALYs) decreased, probably attributed to improved disease management strategies. These trends were particularly evident in regions with a high Socio-Demographic Index (SDI), potentially associated with vaccination efforts, and significant reductions in DALYs were observed in low- and middle-SDI regions, likely owing to advancements in healthcare.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 10","pages":"Article 102868"},"PeriodicalIF":4.0000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125002175","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Varicella-zoster virus (VZV) infection gives rise to varicella (chickenpox) and herpes zoster (HZ, shingles). Primary VZV infection results in varicella, while HZ occurs as a consequence of latent VZV reactivation. Older adults are at a significantly elevated risk of HZ because of age-related immune senescence. This study was designed to evaluate the global burden and trends of VZV-related diseases (VHZ: varicella and HZ) among adults aged ≥70 years from 1997 to 2021 and to explore the influencing factors. In this specific age group, VHZ predominantly refers to HZ.
Methods
Data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 were employed to estimate the incidence, disability-adjusted life years (DALYs), and rates of VHZ in older adults. Estimated annual percentage changes were utilized to quantify trends, and demographic decomposition analysis was conducted to determine the impacts of population aging, growth, and epidemiological changes.
Results
In 2021, a total of 4,539,519 new VHZ cases were reported globally among older adults, with an incidence rate of 918.2 per 100,000. The global DALYs attributable to VHZ amounted to 113,013, corresponding to a DALY rate of 22.9 per 100,000. From 1997 to 2021, although the incidence rate increased slightly, the DALY rate declined significantly. Population growth was the main driver of the increase in the number of cases, whereas enhanced disease management contributed to the reduction in DALYs.
Conclusions
From 1997 to 2021, the incidence of VHZ in adults aged ≥70 years increased marginally due to population growth, while the disease burden (measured by DALYs) decreased, probably attributed to improved disease management strategies. These trends were particularly evident in regions with a high Socio-Demographic Index (SDI), potentially associated with vaccination efforts, and significant reductions in DALYs were observed in low- and middle-SDI regions, likely owing to advancements in healthcare.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.